Genesis Healthcare, Inc. (GENN)
OTCMKTS: GENN · Delayed Price · USD
0.0001
-0.0010 (-90.91%)
Mar 27, 2024, 12:00 AM EDT - Market open
Genesis Healthcare Market Cap
Genesis Healthcare has a market cap or net worth of $2.04 million as of March 28, 2024. Its market cap has decreased by -98.75% in one year.
Market Cap
2.04M
Enterprise Value
n/a
1-Year Change
-98.75%
Ranking
n/a
Category
Stock Price
$0.00
Market Cap Chart
Since May 15, 2007, Genesis Healthcare's market cap has decreased from $595.30M to $2.04M, a decrease of -99.66%. That is a compound annual growth rate of -33.58%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Mar 25, 2021 | 70.30M | -12.89% |
Mar 24, 2021 | 80.70M | -3.58% |
Mar 23, 2021 | 83.70M | -8.42% |
Mar 22, 2021 | 91.40M | -8.96% |
Mar 19, 2021 | 100.40M | 12.56% |
Mar 18, 2021 | 89.20M | -4.09% |
Mar 17, 2021 | 93.00M | -4.71% |
Mar 16, 2021 | 97.60M | 0.93% |
Mar 15, 2021 | 96.70M | 3.31% |
Mar 12, 2021 | 93.60M | -0.85% |
Mar 11, 2021 | 94.40M | -0.74% |
Mar 10, 2021 | 95.10M | -4.80% |
Mar 9, 2021 | 99.90M | 19.35% |
Mar 8, 2021 | 83.70M | 4.76% |
Mar 5, 2021 | 79.90M | 0.25% |
Mar 4, 2021 | 79.70M | -4.78% |
Mar 3, 2021 | 83.70M | -38.14% |
Mar 2, 2021 | 135.30M | -1.17% |
Mar 1, 2021 | 136.90M | 3.48% |
Feb 26, 2021 | 132.30M | -0.38% |
Feb 25, 2021 | 132.80M | -7.52% |
Feb 24, 2021 | 143.60M | 2.50% |
Feb 23, 2021 | 140.10M | -9.50% |
Feb 22, 2021 | 154.80M | -0.83% |
Feb 19, 2021 | 156.10M | -3.82% |
View and export this data all the way back to 2007.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Eli Lilly | 739.87B |
Novo Nordisk | 574.20B |
UnitedHealth Group | 454.53B |
Johnson & Johnson | 380.65B |
Merck & Co. | 333.68B |
AbbVie | 320.44B |
Thermo Fisher | 220.92B |
AstraZeneca | 210.70B |